What TRUPCR Europe does

TRUPCR Europe Ltd is a privately held UK molecular diagnostics company incorporated in England and Wales (company no. 12060630) and operated from Manchester Science Park under the seller entity HS BioLabs Ltd. It develops, manufactures, and supplies qPCR and NGS-based diagnostic kits across four core product lines: oncology and haematology (including individual mutation kits, multi-gene panels, BCR-ABL1 quantitative kits, NGS panel kits, and digital PCR kits), infectious disease (respiratory, meningitis, gastrointestinal, sepsis, transplant, tropical fever, STI, and viral panels), human genetics (thrombophilia, MTHFR, HLA-B27), and antimicrobial resistance (UTI AST, ESKAPE, ESBL, CRE, MRSA, VRE, drug-resistant MTB). The portfolio is completed by nucleic acid extraction kits using silica column and magnetic bead technologies, and by two companion software products — TRUassist for automated qPCR interpretation and reporting, and the TruNGS bioinformatics pipeline for NGS data QC, analysis, and reporting — with bidirectional LIMS integration.

The company's technology is positioned as an open-platform architecture, with kits validated across Applied Biosystems, Bio-Rad, QuantStudio, Rotor-Gene, Roche LightCycler, Agilent AriaMx, Illumina, and MGI instruments, eliminating instrument lock-in. Manufacturing is conducted under an ISO 13485:2016 quality management system certified by BSI, and select kits carry CE-IVD marking. The business sells through a direct enterprise field-sales model, quote-based pricing, and active participation in European and US trade shows (Medica, ESHG, ESCMID, ECCMID, IBMS Congress, ACGS, Festival of Genomics), serving hospital laboratories, NHS trusts, clinical microbiology labs, reference labs, and genetics testing facilities across at least seven countries (UK, Germany, Italy, Sweden, USA, Ireland, Denmark).

The company is founder-led (Harry Singh, co-founder/director) with 1-10 employees, no disclosed external funding, no disclosed revenue, and pricing not publicly available. Operating geographies span Europe and North America via worldwide distribution, and the customer base comprises named accounts such as Manchester NHS, Liverpool NHS, Synlab, Health Services Lab, OnkoMedeor, and Klinik Facoriten, indicating an early-to-mid-stage commercial diagnostic kit supplier rather than a scaled platform.

Name

TRUPCR Europe

Legal name

TRUPCR Europe Ltd

Website

https://trupcr.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

TRUPCR Europe Ltd is a UK-based molecular diagnostics company that develops and supplies qPCR, NGS, and digital PCR kits for oncology, infectious disease, human genetics, and antimicrobial resistance, plus companion interpretation software, serving hospital and clinical laboratories worldwide.

Ownership category

akta.pro rank

Product category

Molecular Diagnostic Kits

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

akta.pro secondary industries

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Infectious Disease POCT (Respiratory, STI, HIV, Sepsis) (HLAHAOAA)

Keywords

• Molecular diagnostic kits
• Real-time PCR assays
• Next-generation sequencing panels
• Nucleic acid extraction kits
• Clinical bioinformatics software

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Diagnostic Kit Sales: Sale of molecular diagnostic kits for qPCR and NGS applications. Products include individual marker kits, panel kits, extraction kits, and standards. Pricing quote-based through sales team contact.
2. Software Licenses: TRUassist and TruNGS software sold as companion products for data interpretation. Software enables automated analysis and reporting for TRUPCR infectious disease and oncology kits.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

TRUPCR Europe develops, manufactures and supplies molecular diagnostic kits for qPCR and NGS workflows across oncology, haematology, infectious disease, human genetics, antimicrobial resistance and nucleic acid extraction. Its offering also includes TRUassist qPCR interpretation and reporting software and the TruNGS bioinformatics pipeline for automated NGS quality control, analysis and reporting.

Product overview

TRUPCR Europe is a molecular diagnostics company that develops, manufactures, and supplies high-quality qPCR and NGS molecular diagnostic products. Its product portfolio consists of four core offerings: (1) TRUPCR Oncology and Haematology Molecular Diagnostic Kits covering individual markers (C-KIT, CALR, FLT3, NPM1, JAK2, PML-RARA, MPL, MYD88, CXCR4, IDH1/2, EGFR, KRAS, MGMT, BRAF, NRAS, ROS1, ALK, DPYD, TPMT, PIK3CA), multi-gene panel kits (ALL, AML, MPN, Paediatric Leukaemia, Leukemia Fusion Gene, Acute Leukaemia, Colorectal Cancer, Lung Cancer), BCR-ABL1 kits, Digital PCR kits (BCR::ABL1, JAK2 V617F), NGS Panel Kits (truNGS BRCA Plus, Solid Tumor, Endometrial Cancer, Pan-Myeloid), and reference standards; (2) TRUPCR Infectious Disease Kits spanning panel kits (Influenza, Flu/RSV, Neuro, STD, Sepsis, TORCH, UTI, Transplant, Gastrointestinal, Tropical Fever, Respiratory, Meningitis), viral disease kits (CMV, EBV, HBV, HCV, HIV, HPV, SARS-CoV-2, H1N1, HMPV, Adenovirus), bacterial kits (CT/NG, MTB/NTM, Leptospira, C. difficile), parasitic kits (Toxoplasma, Malaria), and vector-borne kits (Zika, Chikungunya, Dengue, Malaria); (3) TRUPCR Human Genetics Kits for Factor II, Factor V Leiden, MTHFR, Thrombophilia Panel, and HLA B27; (4) TRUPCR Antimicrobial Resistance Kits including UTI AST Panel, ESKAPE ID and AMR Panel, ESBL Detection, Carbapenem Resistance Detection, MRSA, VRSA, VRE, and Rifampicin/INH MTB Drug Resistant Detection. Supporting these core products are two software add-ons: TRUassist Interpretation Software for automated qPCR data analysis and reporting in infectious disease and oncology applications; and TruNGS Bioinformatics Pipeline for automated NGS data analysis and reporting. TRUPCR also offers a comprehensive range of extraction kits using silica column and MagBead technologies for DNA and RNA purification from diverse sample types. All products are manufactured within an ISO 13485:2016-certified quality management system, with some kits carrying CE-IVD marking.

Differentiator

Problem solved

Functional benefit

Brands

• truNGS: NGS (Next-Generation Sequencing) panel kits product line including BRCA Plus, Solid Tumor Panel, Endometrial Cancer Panel, and Pan-Myeloid Panel kits with associated bioinformatics pipeline software.
• TRUassist

Products and services

• TRUPCR Oncology and Haematology Molecular Diagnostic Kits Portfolio of qPCR, digital PCR and NGS kits, reference standards, individual-marker and panel assays for genetic mutations, fusion genes, biomarkers and BCR-ABL1 monitoring in haematological malignancies and solid tumours. Intended for hospital, clinical pathology and molecular diagnostic laboratories.
• TRUPCR Infectious Disease Molecular Diagnostic Kits Portfolio of molecular diagnostic kits for detecting viral, bacterial, parasitic and fungal pathogens. It includes multi-pathogen panels for respiratory, meningitis, gastrointestinal, TORCH, tropical fever, sepsis, UTI, transplant and sexually transmitted infections, as well as individual pathogen detection kits.
• TRUPCR Human Genetics Testing Kits qPCR-based kits for detecting Factor II Prothrombin, Factor V Leiden, MTHFR and HLA-B27 genetic markers, used for thrombophilia risk assessment and ankylosing spondylitis diagnosis in clinical genetics workflows.
• TRUPCR Antimicrobial Resistance Detection Kits Multiplex real-time PCR kits for detecting antimicrobial resistance genes in clinical samples or cultured isolates, including UTI AST, ESKAPE ID and AMR, ESBL, carbapenem resistance, MRSA, VRSA, VRE and drug-resistant MTB assays.
• TRUPCR Extraction Kits Silica-column and magnetic-bead kits for DNA and RNA purification from whole blood, FFPE tissue, plasma, serum, sputum, urine, bacteria, fungi and viruses for downstream qPCR, NGS and other molecular applications.
• TRUassist Interpretation Software (Infectious Diseases) Automated analysis and reporting software for TRUPCR infectious disease panel kits that interprets Ct values, validates controls, performs calculations, creates sample-wise PDF reports and provides color-coded run dashboards and LIS-ready exports.
• TRUassist Interpretation Software (Oncology) Automated analysis and reporting software for TRUPCR oncology kits, including ALL, AML, BCR-ABL1, DPYD, EGFR, JAK2, MGMT, NPM1 and MPN assays. It supports data from Applied Biosystems, Bio-Rad and Agilent real-time PCR systems.
• TruNGS Bioinformatics Pipeline Automated NGS bioinformatics software for truNGS panel kits that provides quality control, secondary and tertiary analysis, annotation, customizable reporting, bidirectional LIMS integration, sequencer integration and long-term data storage and retrieval. It is compatible with Illumina and MGI sequencing platforms and is labeled Research Use Only.

Quantifiable outcome

• Validated on major real-time PCR platforms including Applied Biosystems, Bio-Rad, QuantStudio, Rotor-Gene
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration49 records

AI capability1 record

Feature7 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Bio-Rad manufactures CFX real-time PCR instruments and a broad range of qPCR reagents/diagnostics kits for infectious disease and oncology, overlapping directly with TRUPCR's validated-on-CFX product strategy.
• ELITech Group: ELITech is a European-headquartered specialist in molecular diagnostics kits (qPCR) for infectious disease and genetics, a size and geographic peer to TRUPCR Europe competing in the same European hospital lab market.
• Promega Corporation: Promega supplies nucleic acid extraction reagents, qPCR master mixes, and genetic identity/testing kits for clinical and research labs, comparable to TRUPCR's extraction and qPCR kit offerings.
• Hain Lifescience (Bruker): Hain Lifescience (now part of Bruker) is a European molecular diagnostics specialist offering qPCR kits for infectious disease and genetics, a comparable niche European player to TRUPCR Europe.
• Qiagen: Qiagen is a global leader in molecular diagnostics kits, sample preparation, and qPCR/NGS assays for oncology, infectious disease, and genetics — directly comparable to TRUPCR's IVD reagent portfolio across the same end-customer segments.
• Meridian Bioscience (Revvity): Meridian manufactures molecular diagnostic kits for infectious disease (including respiratory, TORCH, and gastrointestinal pathogens), directly comparable to TRUPCR's infectious disease panel kits.
• QuantaBio (VWR/Avantor): QuantaBio develops qPCR and NGS reagents/kits for clinical diagnostics and research, including sample-prep and gene expression assays, closely mirroring TRUPCR's molecular diagnostics positioning.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is a global IVD incumbent with cobas real-time PCR systems and a deep molecular diagnostics menu across infectious disease, oncology, and genetics — competing broadly with TRUPCR's portfolio through instrument-bundled reagent contracts.
• Abbott Molecular: Abbott Molecular supplies m2000 and Alinity m real-time PCR platforms with IVD assays for infectious disease, oncology, and genetics — a large incumbent with overlapping menu and channels to TRUPCR's target hospital lab customers.
• Cepheid (Danaher): Cepheid's GeneXpert is a leading molecular POCT/IVD platform with infectious disease and oncology menus, a broad incumbent that competes for the same clinical lab testing budget that TRUPCR targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/trupcr

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TRUPCR Europe